Previous 10 | Next 10 |
Gainers: KalVista Pharmaceuticals KALV +134%, Heat Biologics HTBX +70%, Iterum Therapeutics (ITRM) +48%, OrganiGram OGI +47%, Oragenics (OGEN) +24%.Losers: Aeterna Zentaris (AEZS) -27%, Ekso Bionics EKSO -23%, Ocugen OCGN -...
Gainers: Ocugen (OCGN) +230%.ARYA Sciences Acquisition (ARYA) +101%.CRH Medical (CRHM) +81%.BSQUARE (BSQR) +72%.Esports Entertainment (GMBL) +51%.Outlook Therapeutics (OTLK) +50%.Aeterna Zentaris (AEZS) +46%.Westport Fuel Systems (WPRT) +43%.Nxt-ID (NXTD) +37%.OrganiGram (OGI) +37%....
Gainers: Cassava Sciences (SAVA) +126%.Ocugen (OCGN) +75%.American Resources (AREC) +51%.Lizhi (LIZI) +46%.Aeterna Zentaris (AEZS) +35%.Moleculin Biotech (MBRX) +35%.Holicity (HOL) +35%.Prothena (PRTA) +32%.TETRA Technologies (TTI) +32%.Artelo Biosciences (ARTL) +29%.Losers: Ga...
Cheap Penny Stocks To Buy For Under $3 But Are They Too High Risk? There are plenty of penny stocks to choose from. But which ones are the right ones to buy right now? You could, of course, look for different sector trends to find opportunities. On the other hand, you could look for...
Aeterna Zentaris (AEZS) soars 53% premarket in reaction to the announcement that it has entered into an exclusive option agreement to evaluate a potential COVID-19 vaccine developed at the Julius-Maximilians-University Wuerzburg.The vaccine technology developed at the University use...
- Company secures next step to continue to build-out pipeline of assets - University researchers developed a proprietary and orally active bacterial vaccine platform technology currently undergoing pre-clinical studies for the prevention of coronavirus diseases, including COVID-19...
Aeterna Zentaris (AEZS) +5.3% has licensed the exclusive worldwide rights to develop, manufacture and commercialize targeted, highly specific, autoimmunity modifying proteins (“AIM Biologicals”) for the potential treatment of neuromyelitis optica spectrum disorder ((NM...
- Company licenses exclusive worldwide rights to develop, manufacture and commercialize targeted, highly specific immunosuppressive therapeutic proteins for the potential treatment of neuromyelitis optica spectrum disorder (“NMOSD”) from Julius-Maximilians-University...
Aeterna Zentaris ([[AEZS]] +6.8%) received a notification letter from Nasdaq Stock Market notifying the Company that it has been granted an additional 180 calendar day period until July 26, 2021 to regain compliance with the minimum bid price requirement for continued listing.T...
Are These The Best Penny Stocks To Buy Today? In this article, we’ll go over some of the basics of penny stocks . What are they, how do you find them, and should you buy them? I’ll also go into detail on 4 of these cheap stocks that have begun trending mid-week. Will t...
News, Short Squeeze, Breakout and More Instantly...
Aeterna Zentaris Inc. Company Name:
AEZS Stock Symbol:
NASDAQ Market:
Aeterna Zentaris Inc. Website:
2024-07-17 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for he...
Aeterna Zentaris Inc. (NASDAQ: AEZS) is one of today's top gainers. The company's shares have moved 24.97% on the day to $6.7. Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimore...